DE PLACIDO, SABINO
DE PLACIDO, SABINO
DIPARTIMENTO DI SANITA' PUBBLICA
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
1999 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells.
2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity
2003 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; ZANGEMEISTER WITTKE, U; Ciardiello, F.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
2005 Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor.
2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
ZD1839 (Iressa): preclinical studies and pharmacology
2002 Ciardiello, F; Tortora, G; DE PLACIDO, Sabino; Bianco, Ar
RESULTS OF ADJUVANT TREATMENT IN BREAST CANCER WOMEN AGED MORE THAN 70: ITALIAN COOPERATIVE GROUP EXPERIENCE.
2002 Mustacchi, G; Ceccherini, R; Pluchinotta, A; DE MATTEIS, Maria Antonietta; Maiorino, L; Farris, A; Scanni, A; DE PLACIDO, Sabino
Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives.
2003 Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M.
COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER.
2004 Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora
[The request for consent in clinical research: a randomized study in healthy subjects]
1995 F., Perrone; DE PLACIDO, Sabino; C., Giusti; C., Gallo
Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study.
2004 Maddalena, Barba; Susan E., Mccann; Holger J., Schünemann; Saverio, Stranges; Barbara, Fuhrman; DE PLACIDO, Sabino; Giuseppe, Carruba; Jo L., Freudenheim; Maurizio, Trevisan; Marcia, Russell; Tom, Nochajski; Paola, Muti
Insurance for independent cancer trials.
2004 F., Perrone; M., Marangolo; F., Di Costanzo; G., Colucci; L., Repetto; M., Merlano; DE PLACIDO, Sabino; V., Torri; G., Comella; R., Labianca; V., Parisi; C., Gallo
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides.
2005 DI LORENZO, Giuseppe; R., Di Trolio; M., Delfino; DE PLACIDO, Sabino
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.
1990 DE PLACIDO, Sabino; C., Gallo; Marinelli, Alfredo; F., Perrone; Pagliarulo, Clorindo; Petrella, Giuseppe; Delrio, Giovanni; M., D'Istria; L., Del Mastro; Bianco, ANGELO RAFFAELE
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer.
1989 M., Lopez; Contegiacomo, Alma; P., Vici; C., Dello Ioio; L., Di Lauro; Pagliarulo, Clorindo; S., Carpano; D., Giannarelli; DE PLACIDO, Sabino; Fazio, Serafino
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
1988 R. V., Iaffaioli; A., Bianchin; Ruggiero, Giuseppina; G., Pirozzi; A., Ungaro; G., Totaro; C., Gallo; DE PLACIDO, Sabino; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen.
1986 Delrio, Giovanni; DE PLACIDO, Sabino; Pagliarulo, Clorindo; M., D'Istria; S., Fasano; Marinelli, Alfredo; F., Citarella; L., De Sio; Contegiacomo, Alma; R. V., Iaffaioli
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. | 1.1 Articolo in rivista | 2000 | Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, | |
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. | 1.1 Articolo in rivista | 1999 | Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo | |
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo | |
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity | 1.1 Articolo in rivista | 2003 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; ZANGEMEISTER WITTKE, U; Ciardiello, F. | |
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. | 1.1 Articolo in rivista | 2004 | Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G. | |
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. | 1.1 Articolo in rivista | 2005 | Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
ZD1839 (Iressa): preclinical studies and pharmacology | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Ciardiello, F; Tortora, G; DE PLACIDO, Sabino; Bianco, Ar | |
RESULTS OF ADJUVANT TREATMENT IN BREAST CANCER WOMEN AGED MORE THAN 70: ITALIAN COOPERATIVE GROUP EXPERIENCE. | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Mustacchi, G; Ceccherini, R; Pluchinotta, A; DE MATTEIS, Maria Antonietta; Maiorino, L; Farris, A; Scanni, A; DE PLACIDO, Sabino | |
Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M. | |
COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER. | 1.1 Articolo in rivista | 2004 | Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora | |
[The request for consent in clinical research: a randomized study in healthy subjects] | 1.1 Articolo in rivista | 1995 | F., Perrone; DE PLACIDO, Sabino; C., Giusti; C., Gallo | |
Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study. | 1.1 Articolo in rivista | 2004 | Maddalena, Barba; Susan E., Mccann; Holger J., Schünemann; Saverio, Stranges; Barbara, Fuhrman; DE PLACIDO, Sabino; Giuseppe, Carruba; Jo L., Freudenheim; Maurizio, Trevisan; Marcia, Russell; Tom, Nochajski; Paola, Muti | |
Insurance for independent cancer trials. | 1.1 Articolo in rivista | 2004 | F., Perrone; M., Marangolo; F., Di Costanzo; G., Colucci; L., Repetto; M., Merlano; DE PLACIDO, Sabino; V., Torri; G., Comella; R., Labianca; V., Parisi; C., Gallo | |
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides. | 1.1 Articolo in rivista | 2005 | DI LORENZO, Giuseppe; R., Di Trolio; M., Delfino; DE PLACIDO, Sabino | |
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. | 1.1 Articolo in rivista | 1990 | DE PLACIDO, Sabino; C., Gallo; Marinelli, Alfredo; F., Perrone; Pagliarulo, Clorindo; Petrella, Giuseppe; Delrio, Giovanni; M., D'Istria; L., Del Mastro; Bianco, ANGELO RAFFAELE | |
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. | 1.1 Articolo in rivista | 1989 | M., Lopez; Contegiacomo, Alma; P., Vici; C., Dello Ioio; L., Di Lauro; Pagliarulo, Clorindo; S., Carpano; D., Giannarelli; DE PLACIDO, Sabino; Fazio, Serafino | |
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients. | 1.1 Articolo in rivista | 1988 | R. V., Iaffaioli; A., Bianchin; Ruggiero, Giuseppina; G., Pirozzi; A., Ungaro; G., Totaro; C., Gallo; DE PLACIDO, Sabino; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. | 1.1 Articolo in rivista | 1986 | Delrio, Giovanni; DE PLACIDO, Sabino; Pagliarulo, Clorindo; M., D'Istria; S., Fasano; Marinelli, Alfredo; F., Citarella; L., De Sio; Contegiacomo, Alma; R. V., Iaffaioli |